Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis
The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: An increased prevalence of functional hyperandrogenism—including polycystic ovary syndrome (PCOS)—has been described in women with type 1 diabetes (T1D). However, heterogeneity between studies is frequent, and prevalence rates vary according to different criteria used for the diagnosis of PCOS and the population studied. OBJECTIVE AND RATIONALE: We aimed to perform a systematic review and meta-analysis of the prevalence of PCOS and related hyperandrogenic traits in premenopausal women with T1D. This way, we intend to increase the precision of the estimates of prevalence of PCOS and related traits in women with T1D, and to explore sources of heterogeneity while providing prevalence estimates for clinically relevant subgroups such as the different phenotypes. SEARCH METHODS: We conducted a systematic review of the literature using Medline-OVID and Embase databases (Open Science Framework registry for systematic review protocols, https://osf.io/6cv9p/). Studies published up to 29 March 2021 were considered. We selected cross-sectional or prospective studies that reported, in patients with T1D, prevalence data on PCOS according to current definitions and different phenotypes, and/or prevalence rates of other related traits (hirsutism, hyperandrogenaemia, oligo-amenorrhoea and/or polycystic ovarian morphology: PCOM). Exclusion criteria for the review were studies addressing types of diabetes other than T1D; and studies using diagnostic definitions of PCOS different than those mentioned above. Two independent researchers performed data extraction. To assess the risk of bias, we used a tool developed specifically to appraise population-based prevalence studies. OUTCOMES: We selected 19 studies (1042 women) reporting the prevalence of PCOS and/or other hyperandrogenic traits. Regarding bias, 12 studies were considered of low-risk, and the remaining seven studies were considered intermediate risk. The pooled prevalence of PCOS when considering all possible phenotypes (ESHRE- American Society for Reproductive Medicine criteria) in T1D was 26% (95% CI: 19–34%; 13 studies, 684 women). Pooled prevalence of classic PCOS (US National Institutes of Health criteria) was 16% (95% CI: 10–22%; 9 studies, 614 women). Pooled prevalence of hyperandrogenic PCOS (Androgen Excess and PCOS Society criteria) was 26% (95% CI: 16–41%; 5 studies, 329 women). Hirsutism (24%), hyperandrogenaemia (29%), oligomenorrhoea (24%) and PCOM (34%) were also prevalent. Heterogeneity was high in almost all these meta-analyses. WIDER IMPLICATIONS: This systematic review and meta-analysis showed that PCOS and related hyperandrogenic traits are present in approximately one in every four women with T1D. Larger studies are needed to confirm this association, to address the effect of different variables on the occurrence of PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Type 1 diabetes has been observed to have a higher prevalence (7%-25%) in those with PCOS, and in those with menstrual and reproductive dysfunction, and this has been associated with hyperandrogenemia.110, 111, 112, 113, 114”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [113]
Citations
Cites
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003583 · Cited by 5,148
Hoy, D., Brooks, P., Woolf, A., Blyth, F., March, L., Bain, C., Baker, P., Smith, E., & Buchbinder, R. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.11.014 · Cited by 2,555
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Self-citationPolycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Self-citationAsunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Self-citationWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Self-citationThe Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 818
Asuncion, M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2434 · Cited by 791
Dewailly, D., Lujan, M. E., Carmina, E., Cedars, M. I., Laven, J., Norman, R. J., & Escobar-Morreale, H. F. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt061 · Cited by 551
Self-citationAbdominal adiposity and the polycystic ovary syndrome
Escobar-Morreale, H. F., & Millán, J. L. S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.07.003 · Cited by 386
Self-citationCARA, J. F., & ROSENFIELD, R. L. (1988) · Endocrinology · doi:10.1210/endo-123-2-733 · Cited by 336
Polycystic Ovary Syndrome: A Syndrome of Ovarian Hypersensitivity to Insulin?
Baillargeon, J.-P., & Nestler, J. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1804 · Cited by 169
Menstrual Cycle Differences Between Women With Type 1 Diabetes and Women Without Diabetes
Strotmeyer, E. S., Steenkiste, A. R., Foley, T. P., Berga, S. L., & Dorman, J. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1016 · Cited by 135
Codner, E., Soto, N., Lopez, P., Trejo, L., Ávila, A., Eyzaguirre, F. C., Íniguez, G., & Cassorla, F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0108 · Cited by 129
Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis
Escobar-Morreale, H. F., & Roldán-Martín, M. B. (2016) · Diabetes Care · doi:10.2337/dc15-2577 · Cited by 123
Self-citationKjaer, K., Hagen, C., Sandø, S. H., & Eshøj, O. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1639955 · Cited by 122
Escobar-Morreale, H. F., Roldán, B., Barrio, R., Alonso, M., Sancho, J., de la Calle, H., & GarcÍa-Robles, R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6931 · Cited by 114
Self-citationHyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus
Codner, E., & Escobar-Morreale, H. F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2641 · Cited by 112
Self-citationAzziz, R., Kintziger, K., Li, R., Laven, J., Morin-Papunen, L., Merkin, S. S., Teede, H., & Yildiz, B. O. (2019) · Human Reproduction · doi:10.1093/humrep/dez185 · Cited by 108
Polycystic ovary syndrome: evolution of a concept
Ruutiainen, K., & Seppälä, M. (1991) · Current Opinion in Obstetrics and Gynecology · doi:10.1097/00001703-199106000-00004 · Cited by 99
Insulin sensitivity in Type 1 diabetic children and adolescents
Szadkowska, A., Pietrzak, I., Mianowska, B., Bodalska‐Lipińska, J., Keenan, H. A., Toporowska‐Kowalska, E., Młynarski, W., & Bodalski, J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02357.x · Cited by 90
Sanchon, R., Gambineri, A., Alpanes, M., Martinez-Garcia, M. A., Pasquali, R., & Escobar-Morreale, H. F. (2012) · Human Reproduction · doi:10.1093/humrep/des028 · Cited by 89
Self-citationAmin, R., Schultz, C., Ong, K., Frystyk, J., Dalton, R. N., Perry, L., Ørskov, H., & Dunger, D. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1456 · Cited by 85
de Zegher, F., & Ibáñez, L. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.013 · Cited by 83
Puberty and Ovarian Function in Girls with Type 1 Diabetes Mellitus
Codner, E., & Cassorla, F. (2009) · Hormone Research in Paediatrics · doi:10.1159/000173737 · Cited by 77
Adcock, C. J., Perry, L. A., Lindsell, D. R. M., Taylor, A. M., Holly, J. M. P., Jones, J., & Dunger, D. B. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00307.x · Cited by 71
Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4182 · Cited by 67
Self-citationHormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
Codner, E., Iñíguez, G., Villarroel, C., Lopez, P., Soto, N., Sir-Petermann, T., Cassorla, F., & Rey, R. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1252 · Cited by 65
Menarche delay and menstrual irregularities persist in adolescents with type 1 diabetes
Schweiger, B. M., Snell-Bergeon, J. K., Roman, R., McFann, K., & Klingensmith, G. J. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-61 · Cited by 61
Identification of the Source of Androgen Excess in Hyperandrogenic Type 1 Diabetic Patients
Roldán, B., Escobar-Morreale, H. F., Barrio, R., de la Calle, H., Alonso, M., García-Robles, R., & Sancho, J. (2001) · Diabetes Care · doi:10.2337/diacare.24.7.1297 · Cited by 48
Self-citationSnell-Bergeon, J. K., Dabelea, D., Ogden, L. G., Hokanson, J. E., Kinney, G. L., Ehrlich, J., & Rewers, M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2025 · Cited by 46
Amato, M. C., Guarnotta, V., Ciresi, A., Modica, R., Pantò, F., & Giordano, C. S. D. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2669 · Cited by 37
Samara-Boustani, D., Colmenares, A., Elie, C., Dabbas, M., Beltrand, J., Caron, V., Ricour, C., Jacquin, P., Tubiana-Rufi, N., Levy-Marchal, C., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0670 · Cited by 37
Zachurzok, A., Deja, G., Gawlik, A., Drosdzol-Cop, A. B., & Małecka‐Tendera, E. (2013) · PubMed · Cited by 29
Busiah, K., Colmenares, A., Bidet, M., Tubiana‐Rufi, N., Lévy‐Marchal, C., Delcroix, C., Jacquin, P., Martin, D., Benadjaoud, L., Jacqz-Aigrain, É., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000471805 · Cited by 29
Bizzarri, C., Benevento, D., Ravà, L., Patera, I. P., Schiaffini, R., Ciampalini, P., Giannone, G., & Cappa, M. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.023 · Cited by 27
Miyoshi, A., Nagai, S., Takeda, M., Kondo, T., Nomoto, H., Kameda, H., Hirai, A., Cho, K., Kimachi, K., Shimizu, C., et al. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12040 · Cited by 25
Metabolic risk factors in adolescent girls with type 1 diabetes
Castro-Correia, C., Silva, R. S., Pinheiro, M. I., Costa, C., & Fontoura, M. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0053 · Cited by 18
Thong, E. P., Milat, F., Joham, A. E., Mishra, G. D., & Teede, H. J. (2020) · Clinical Endocrinology · doi:10.1111/cen.14281 · Cited by 17
Łebkowska, A., Adamska, A., Krentowska, A., Uruska, A. A., Rogowicz‐Frontczak, A., Araszkiewicz, A., Ożegowska, K., Hryniewicka, J., Leśniewska, M., Wender-Ożegowska, E., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab062 · Cited by 14
Paschou, S. Α., Vryonidou, A., Melissourgou, M., Kosteria, I., Goulis, D. G., Chrousos, G. P., & Kanaka‐Gantenbein, C. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0153 · Cited by 13
Gunness, A., Pazderska, A., Ahmed, M., McGowan, A., Phelan, N., Boran, G. P., TAYLOR, A. E. R., O’Reilly, M., Arlt, W., Moore, K., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey243 · Cited by 12
Reproductive disturbances among Saudi adolescent girls and young women with type 1 diabetes mellitus
Braham, R. B., Robert, A. A., Musallam, M. A., Alanazi, A., Swedan, N. B., & Dawish, M. A. A. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i11.475 · Cited by 10
Research works printed but not linked: 6
- Calliari, 2014, Polycystic ovary syndrome and hyperandrogenism in type 1 diabetes: Adolescent girls are already at risk, Pediatr Diabetes, 15, 106
- Dabadghao, 2016, Prevalence of polycystic ovary syndrome and its clinical profile in young females with type 1 diabetes mellitus, Horm Res Paediatr, 86, 238
- Deja, 2010, Clinical and hormonal profile in adolescent girls with type 1 diabetes mellitus and polycystic vary syndrome or polycystic ovary morphology, Pediatr Diabetes, 11, 20
- Deja, 2009, PCOS and hyperandrogenic disorders—a problem in adolescent girls with type 1 diabetes mellitus and good metabolic control, Pediatr Diabetes, 10, 99
- Kvasnickova, 2010, Occurrence of polycystic ovary syndrome and hyperadrogenemia in women with type 1 diabetes mellitus, Prakt Lek, 90, 224
- Zawadzki, 1992, Polycystic Ovary Syndrome, 377
Cited by
Polycystic ovary syndrome as a metabolic disease
Helvaci, N., & Yildiz, B. O. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01057-w · Cited by 188
Vine, D., Ghosh, M., Wang, T., & Bakal, J. (2024) · CJC Open · doi:10.1016/j.cjco.2023.12.010 · Cited by 53
“113,115”
Myo-inositol in assisted reproductive technology from bench to bedside
Etrusco, A., Laganà, A. S., Chiàntera, V., Buzzaccarini, G., & Unfer, V. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.09.005 · Cited by 48
Dou, Y., Zhang, M., Zhang, H., Zhang, C., Feng, L., Hu, J., Gao, Y., Yuan, X.-Z., Zhao, Y., Zhao, H., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.174972 · Cited by 43
Gonadal dysfunction in women with diabetes mellitus
Zaimi, M., Michalopoulou, O., Stefanaki, K., Kazakou, P., Vasileiou, V., Ψαλτοπούλου, Θ., Karagiannakis, D. S., & Paschou, S. Α. (2024) · Endocrine · doi:10.1007/s12020-024-03729-z · Cited by 35
Metadata
- Authors
- Bayona, A., Martínez-Vaello, V., Zamora, J., Nattero-Chávez, L., Luque-Ramírez, M., & Escobar-Morreale, H. F.
- Affiliations
- Universidad de Alcalá (ES)
- Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal , Madrid, Spain
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-03-03
- Volume
- 28
- Issue
- 4
- Pages
- 501-517
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W4212965655
- Cited by
- 44
- References
- 46
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 10 · 2023: 9 · 2022: 3
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Instituto de Salud Carlos III (PIE16/00050)
- European Development Regional Fund ‘A way (CM19/00138)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- polycystic ovary syndrome, type 1 diabetes, hyperandrogenism, PCOS phenotypes, hirsutism, hyperandrogenemia, polycystic ovary morphology, prevalence, premenopausal women, NIH criteria
- MeSH terms
- Cross-Sectional Studies, Diabetes Mellitus, Type 1, Female, Hirsutism, Humans, Phenotype, Polycystic Ovary Syndrome, Prospective Studies, Prevalence, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.